LAUSR

© BMJ Publishing Group Limited 2021. No commercial reuse. See rights and permissions. Published by BMJ. DESCRIPTION A 28yearold woman presented with complaints of breathlessness on exertion NYHA class II and palpitations for the past 2 years. On examination she had irregularly irregular pulse and middiastolic murmur at the apex. An ECG revealed atrial fibrillation with controlled ventricular rate. Her echocardiogram revealed thickened and doming anterior mitral leaflet, fixed posterior mitral leaflet and subvalvular disease with a mitral valve area of 0.8 cm. There was a teardropshaped thrombus in the left atrial (LA) appendage extending into the left atrium in the parasternal shortaxis view. Also, there was a mobile pedunculated extension to the LA appendage thrombus into the LA cavity, giving the appearance of a boxing glove (figure 1A,B). The flow of blood from the left atrium to the left ventricle could be seen nicely because of the spontaneous echo contrast (figure 1C). The echocardiographic picture was akin to a ‘chainsmoking left atrium, with a punching boxing glove’ (video 1). The patient did not have any signs or symptoms of peripheral embolism. A diagnosis of rheumatic mitral stenosis with LA thrombus was made. The patient was started on warfarin and referred for mitral valve replacement with LA clot removal. LA thrombus is one of the major complications of mitral stenosis. The incidence of LA thrombus in severe rheumatic mitral stenosis is around 30% in those with atrial fibrillation and 6% in those in normal sinus rhythm. 2 Manjunath et al classified LA thrombus into five groups. Type I clot is the most prevalent, while types IV and V are very rare. In various operative series, only around 6% of cases had clot both in the appendage and in the body of left atrium. The predictors of LA thrombus include older age, dilated left atrium (>45 mm), atrial fibrillation and LA appendage velocity <20 cm/s. Patients with types I and IIa LA clot can undergo balloon mitral valvotomy, with manoeuvres to avoid entering the atrial appendage. Rest of the patients need to be put on anticoagulation for 3–6 months and reassessed for resolution of thrombus. Almost all LA appendage clots resolve in this period, but clots in the LA body are less likely to resolve. Type IV thrombus (mobile thrombus), as seen in our patient, carries a higher risk of thromboembolism. Anticoagulation should be done with vitamin K antagonist, as direct oral anticoagulants (DOACs) are not effective in this setting. Since the patient had a large organised LA clot which was unlikely to resolve on anticoagulation and there was extensive subvalvular disease, which would mean lesser chance of successful balloon mitral valvuloplasty, the patient was referred for mitral valve replacement and clot